These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Stem cells and neurodegenerative diseases. Hou L; Hong T Sci China C Life Sci; 2008 Apr; 51(4):287-94. PubMed ID: 18368305 [TBL] [Abstract][Full Text] [Related]
4. Role of oxidative stress and antioxidants in neurodegenerative diseases. Rao AV; Balachandran B Nutr Neurosci; 2002 Oct; 5(5):291-309. PubMed ID: 12385592 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of olfactory dysfunction in neurodegenerative diseases. Barresi M; Ciurleo R; Giacoppo S; Foti Cuzzola V; Celi D; Bramanti P; Marino S J Neurol Sci; 2012 Dec; 323(1-2):16-24. PubMed ID: 23010543 [TBL] [Abstract][Full Text] [Related]
6. What transgenic mice tell us about neurodegenerative disease. Gurney ME Bioessays; 2000 Mar; 22(3):297-304. PubMed ID: 10684590 [TBL] [Abstract][Full Text] [Related]
8. Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches. Clark IA; Vissel B J Alzheimers Dis; 2021; 79(3):931-948. PubMed ID: 33459706 [TBL] [Abstract][Full Text] [Related]
9. Emulation of Physician Tasks in Eye-Tracked Virtual Reality for Remote Diagnosis of Neurodegenerative Disease. Orlosky J; Itoh Y; Ranchet M; Kiyokawa K; Morgan J; Devos H IEEE Trans Vis Comput Graph; 2017 Apr; 23(4):1302-1311. PubMed ID: 28129166 [TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective. Li J; Liu D; Sun L; Lu Y; Zhang Z J Neurol Sci; 2012 Jun; 317(1-2):1-5. PubMed ID: 22410257 [TBL] [Abstract][Full Text] [Related]
15. Neurodegenerative disorders: the role of peroxynitrite. Torreilles F; Salman-Tabcheh S; Guérin M; Torreilles J Brain Res Brain Res Rev; 1999 Aug; 30(2):153-63. PubMed ID: 10525172 [TBL] [Abstract][Full Text] [Related]
16. Back to the future: the 'old-fashioned' way to new medications for neurodegeneration. Lansbury PT Nat Med; 2004 Jul; 10 Suppl():S51-7. PubMed ID: 15298008 [TBL] [Abstract][Full Text] [Related]
17. Biomarkers of neurodegenerative disorders: how good are they? Rachakonda V; Pan TH; LE WD Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967 [TBL] [Abstract][Full Text] [Related]
18. ALS and eye movements. Okuda B Neurology; 1993 Feb; 43(2):451. PubMed ID: 8437724 [No Abstract] [Full Text] [Related]
19. Dynamic Handwriting Analysis for the Assessment of Neurodegenerative Diseases: A Pattern Recognition Perspective. Impedovo D; Pirlo G IEEE Rev Biomed Eng; 2019; 12():209-220. PubMed ID: 29993722 [TBL] [Abstract][Full Text] [Related]
20. [Disorders of eye movements in degenerative diseases of the nervous system]. Sienkiewicz J Neurol Neurochir Pol; 1994; 28(3):385-94. PubMed ID: 8084367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]